Blinding

When you and/or the researchers don't know which group you're in, to keep the results unbiased; you're told if a trial is blinded before you join.

Blinding means that some people in a trial don’t know which group a participant is in. In a single-blind trial, you don’t know; in a double-blind trial, neither you nor the research team knows until the study ends. It sounds strange, but there’s a caring reason behind it.

Knowing which treatment someone is getting can quietly nudge how symptoms are reported or measured — even when no one means for it to. Blinding removes that nudge, so the results reflect the treatment and not our expectations. You’ll always be told up front if a trial is blinded, and your safety is watched closely regardless. It usually pairs with randomization and a control group.